Loading…
China Pharma Holdings, Inc. is projected to decline to $0.6817 by 2027, a -9% move from its current price of $0.7526. CPHI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.6992 | $0.7519 | $0.8086 | -0.09% |
| May 30 | $0.6778 | $0.7512 | $0.8326 | -0.18% |
| May 31 | $0.6617 | $0.7506 | $0.8513 | -0.27% |
| Jun 1 | $0.6484 | $0.7499 | $0.8673 | -0.36% |
| Jun 2 | $0.6368 | $0.7492 | $0.8815 | -0.45% |
| Jun 3 | $0.6264 | $0.7485 | $0.8945 | -0.54% |
| Jun 4 | $0.617 | $0.7479 | $0.9065 | -0.63% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.617 | $0.7479 | $0.9065 | -0.63% |
| Week 2 | $0.5661 | $0.7431 | $0.9755 | -1.26% |
| Week 3 | $0.5292 | $0.7385 | $1.03 | -1.88% |
| Week 4 | $0.4994 | $0.7338 | $1.08 | -2.50% |
| Week 5 | $0.4742 | $0.7292 | $1.12 | -3.11% |
| Week 6 | $0.4523 | $0.7246 | $1.16 | -3.72% |
| Week 7 | $0.4328 | $0.72 | $1.20 | -4.33% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
China Pharma Holdings, Inc. is a healthcare company that develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. It offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Its product lineup includes Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit, Gastrodin injection for tiredness and related brain functions, Bumetanide and other therapies, as well as vitamins and gastrointestinal treatments. The company is based in Haikou, the People's Republic of China, and supplies its products to hospitals and OTC pharmacies through provincial and municipal pharmaceutical logistics companies.
It offers Roxithromycin dispersible tablets, Cefaclor dispersible tablets, Cefalexin capsules, Andrographolide, Clarithromycin granules and capsules, Naproxen Sodium with Pseudophedrine, and a range of hepatocyte growth factors and other drugs for digestive and related diseases. In addition, it markets Vitamin B6 injection, Granisetron Hydrochloride for nausea and vomiting, and health supplements like Noni Enzyme, while providing sanitizers and masks. The company operates within the healthcare sector, delivering medicines and related products across China.
The entity is based in Haikou, PRC, and distributes its portfolio to hospitals and OTC pharmacies via provincial and municipal logistics networks, positioning itself as a domestic pharmaceutical supplier with a broad product catalog.
China Pharma Holdings, Inc. (CPHI) operates in the Healthcare sector with a focus on pharmaceutical products in China. Its current price is $0.7597 and its market capitalization is $30.78M, reflecting a small-cap profile with a widely distributed product line.
The stock is currently ranked 4793 by market capitalization, highlighting its relatively small position in the broader market. The near-term forecast suggests modest price movement, with an average price projected at $0.7597 for 2026 and a long-run outlook showing gradual appreciation toward higher price levels.
Longer-term projections indicate an average price rising to $2.05 by 2050, with a maximum forecast of $4.71 and a minimum of $0.922. The forecast envisions a path from neutral to bullish sentiment in the later years, with substantial upside potential by 2050.
A major floor 84.5% below — a decisive break under it would weaken the trend.
The nearest floor, 30.9% below — buyers have tended to step in here.
The nearest ceiling, 64.8% above — a clean break opens room to run.
A major ceiling 106.8% above — clearing it would confirm fresh momentum.
Key CPHI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CPHI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.748 | Buy | $0.7629 | Sell |
| MA 10 | $0.848 | Sell | $0.7672 | Sell |
| MA 20 | $0.709 | Buy | $0.7372 | Buy |
| MA 50 | $0.6572 | Buy | $0.7142 | Buy |
| MA 100 | $0.7727 | Sell | $0.8365 | Sell |
| MA 200 | $1.21 | Sell | $1.16 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.89 | Neutral |
| Stoch RSI (14) | 29.24 | Neutral |
| CCI (20) | 17.40 | Neutral |
| Williams %R (14) | -69.01 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | 41.51 | Buy |
| Bollinger %B (20,2) | 0.55 | Neutral |
| Stochastic %K (14) | 30.99 | Neutral |
| TRIX (15) | 1.06 | Buy |
| Awesome (5,34) | 0.07 | Buy |
| Ultimate (7,14,28) | 31.58 | Neutral |
| Momentum (10) | -0.14 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 0.72 | Buy |
| ADX (14) | 18.08 | Neutral |
| ATR (14) | 0.06 | Info |
The near-term technical picture is bullish, with sentiment labeled as BULLISH. The RSI14 sits at 50, indicating neutral momentum on a momentum scale, while the 50-day moving average is $0.6514 and the 200-day moving average is $1.22.
The stock trades within a 30-day range of $0.4557 to $1.27, giving it room to maneuver within that band. The chart shows a current price near the middle of this range, with a defined support at $0.52 and resistance at $1.24, suggesting a potential test of the resistance if buying pressure persists.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.52 | $0.7526 | $1.07 | 0% | Neutral | |
| $0.4906 | $0.6817 | $1.03 | -9% | Neutral | |
| $0.4183 | $0.6168 | $0.986 | -18% | Bearish | |
| $0.3982 | $0.6181 | $1.04 | -18% | Bearish | |
| $0.5191 | $0.8444 | $1.47 | +12% | Neutral | |
| $0.5852 | $0.9946 | $1.79 | +32% | Bullish | |
| $0.5197 | $0.921 | $1.71 | +22% | Bullish | |
| $0.5286 | $0.9755 | $1.86 | +30% | Bullish | |
| $0.4651 | $0.8928 | $1.75 | +19% | Neutral | |
| $0.3982 | $0.7943 | $1.59 | +6% | Neutral | |
| $0.5131 | $1.14 | $2.51 | +52% | Bullish | |
| $0.9414 | $2.09 | $4.81 | +178% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.52 | $0.7526 | $0.8969 | +0.00% |
| June 2026 | $0.6252 | $0.7497 | $0.9317 | -0.38% |
| July 2026 | $0.5683 | $0.6931 | $0.8834 | -7.55% |
| August 2026 | $0.5579 | $0.6895 | $0.8959 | -0.52% |
| September 2026 | $0.5932 | $0.7413 | $0.9783 | +7.52% |
| October 2026 | $0.5927 | $0.7483 | $1.00 | +0.94% |
| November 2026 | $0.5768 | $0.7348 | $0.9954 | -1.80% |
| December 2026 | $0.6073 | $0.7805 | $1.07 | +6.21% |
Click any year to see its month-by-month CPHI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CPHI could reach as high as $1.07, with a base case around $0.7526 and support toward $0.52 — roughly 0% from $0.7526. A consolidation phase looks the most probable path here.
Expect CPHI to range from $0.4906 to $1.03 through 2027. The $0.6817 average target implies a -9% move from current prices. That is -9% versus the projected 2026 average. Price action looks broadly range-bound.
The CPHI price prediction for 2028 points to an average of $0.6168 (low $0.4183, high $0.986) — a potential decline of -18% on today's $0.7526. Expect choppier, lower action through this leg of the cycle.
In 2029, CPHI is projected to trade between $0.3982 and $1.04, averaging $0.6181 — a potential decline of -18% from today's $0.7526. That is up 0% on the projected 2028 average. A cyclical pullback looks likely — prices rarely move in a straight line.
China Pharma Holdings, Inc.'s 2030 outlook centres on $0.8444, within a $0.5191 to $1.47 range. That is up +37% on the projected 2029 average. That marks a +12% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, CPHI could reach as high as $1.79, with a base case around $0.9946 and support toward $0.5852 — roughly +32% from $0.7526. Momentum favours further upside here.
Expect CPHI to range from $0.5197 to $1.71 through 2032. The $0.921 average target implies a +22% move from current prices. That is -7% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
The CPHI price prediction for 2033 points to an average of $0.9755 (low $0.5286, high $1.86) — a potential gain of +30% on today's $0.7526. Momentum favours further upside here.
In 2034, CPHI is projected to trade between $0.4651 and $1.75, averaging $0.8928 — a potential gain of +19% from today's $0.7526. That is -8% versus the projected 2033 average. A consolidation phase looks the most probable path here.
China Pharma Holdings, Inc.'s 2035 outlook centres on $0.7943, within a $0.3982 to $1.59 range. That is -11% versus the projected 2034 average. That marks a +6% change versus current levels. Price action looks broadly range-bound.
By 2040, CPHI could reach as high as $2.51, with a base case around $1.14 and support toward $0.5131 — roughly +52% from $0.7526. Buyers look set to stay in control over this stretch.
Expect CPHI to range from $0.9414 to $4.81 through 2050. The $2.09 average target implies a +178% move from current prices. That is up +83% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in CPHI today (≈ 1,328.727079 CPHI) could be worth
$2,779.57
+$1,779.57 (+178%) by 2050 · US Dollar
Based on the average projected CPHI price of $2.09 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CPHIwould be worth at today's price.
$1,000 invested in CPHI on May 27, 2025 (≈ 473.933673 CPHI) would be worth
$356.68
-$643.32 (-64.3%) today · 0.36× · US Dollar
Based on a CPHI entry price of $2.11 vs. today's $0.7526.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.71 | $1,060 | +6.0% |
| 1 month ago | $0.59 | $1,275.59 | +27.6% |
| 3 months ago | $0.57 | $1,320.35 | +32.0% |
| 6 months ago | $1.6 | $470.37 | -53.0% |
| 1 year ago | $2.11 | $356.68 | -64.3% |
| All time (5.0y) ago | $300 | $2.51 | -99.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CPHI forecast.
Our base-case forecast reaches $1.50 around 2050.
Implied market cap at $1.50: $60.78M
The multi-year forecast points to a gradual price increase, with 2026 averaging $0.7597 and 2030 averaging $0.8226; by 2050 the average is forecast at $2.05, with a possible peak around $4.71. The long arc of the forecast shows positive upside, highlighted by key years such as 2031 (avg $0.9769, ROI 28.6%), 2032 (avg $0.921, ROI 21.2%), and 2033 (avg $0.9588, ROI 26.2%).
Bearish pacing is evident in 2028 (avg $0.6125, ROI -19.4%) and 2029 (avg $0.6253, ROI -17.7%), followed by a rebound into 2031 and beyond. By 2040 the average price is forecast at $1.12 with ROI of 47.2%, and by 2050 the forecast envisions an average of $2.05, a maximum of $4.71, and a strong bullish sentiment with ROI of 169.7%.
These are estimates and not guarantees; actual results may vary with market conditions, regulatory influences, and company-specific developments.
Tap a question to reveal the answer.
2030 min $0.5054, avg $0.8226, max $1.43; ROI 8.3%; sentiment Neutral.
The forecast shows mixed timing: positive ROIs in years like 2031 (28.6%), 2032 (21.2%), 2033 (26.2%), and a strong long-term upside by 2050 (ROI 169.7%), but bearish phases in 2028 (-19.4%) and 2029 (-17.7%). These are estimates, not guarantees.
Yes. The 2033 forecast max is $1.83, and intermediate years show the max rising to $1.76 in 2031 and $1.83 in 2033, indicating it can exceed $1 in several years.
2026 min $0.52, avg $0.7597, max $1.09; sentiment Neutral.
By 2050 the average price is forecast at $2.05 with a max of $4.71 and a min of $0.922; ROI 169.7%; sentiment Bullish.
China Pharma Holdings, Inc. Community Discussion
0Share your China Pharma Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.